HER2 Support Group Forums - View Single Post - Boehringer Ingelheim Initiates Phase III Clinical Trial With Novel Oral Agent In Adva

News · 09-20-2010, 05:11 AM

Boehringer Ingelheim announced the initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer...

More...

09-20-2010, 05:11 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,123	Boehringer Ingelheim Initiates Phase III Clinical Trial With Novel Oral Agent In Adva Boehringer Ingelheim announced the initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer... More...